Why are sales organizations not excited about price increases?

2023 China Medtech Industry Outlook

Building on ongoing in-depth discussions with leaders in the medtech industry, our 2023 China Medtech Outlook is now out, with key themes highlighted in the article.

Frontiers of CGT in China

According to Nature research in 2021, China accounts for over 50 percent of cell therapy trials worldwide. Today, there are around 400 ongoing CAR-T trials in China across a broad range of targets and diverse indications, from hematology/oncology to solid tumors.

How healthcare payment solutions can evolve to capture patients’ willingness to pay

More than two years after COVID-19 forced businesses to accelerate their digital strategy, consumers are permanently evolving their payment preferences in favor of digital formats, and businesses are adapting to consumers’ needs.

How to prepare your P&MA function for the future – current challenges and best-practice solutions

Is your P&MA function future ready? The increasing complexity of products, intensified competition, evolution of payers’ needs, and stricter healthcare systems are some of the factors that have increased the need to check in on your P&MA function!

UK: Integrated Care Systems – lessons and outlook from the first six months

In July 2022, Integrated Care Systems (ICSs) became the statutory bodies responsible for commissioning medicines and budget allocation, replacing Clinical Commissioning Groups (CCGs).

Spain: Pharmaco-economic analyses and their implications

Pharmaco-economic analyses are gaining momentum in Spain, but what are the potential implications?

China: Commercial health insurance trends

While the National Reimbursement Drug List (NRDL) continues to be the dominant path to public reimbursement in China, commercial health insurance (CHI) in China is quickly emerging as an alternative reimbursement option.

Germany: How the GKV-FinStG law is transforming the pharma P&R landscape

In November 2022, the new GKV Financial Stabilization Act (GKV-FinStG) came into effect after being passed by the German parliament.

Better Health: Let’s rethink healthcare

From new vaccines to lifestyle apps, smart watches, and weight loss therapies – the opportunities for healthcare to deliver more value seem endless.